|
Volumn 2 Suppl 3, Issue , 2004, Pages
|
Update: NCCN breast cancer clinical practice guidelines.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ESTROGEN RECEPTOR;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ARTICLE;
BREAST TUMOR;
CARCINOMA IN SITU;
FEMALE;
HUMAN;
METABOLISM;
PAGET NIPPLE DISEASE;
PATHOLOGY;
PRACTICE GUIDELINE;
SEGMENTAL MASTECTOMY;
SENTINEL LYMPH NODE BIOPSY;
TUMOR INVASION;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CARCINOMA IN SITU;
CARCINOMA, DUCTAL, BREAST;
CHEMOTHERAPY, ADJUVANT;
FEMALE;
HUMANS;
MASTECTOMY, SEGMENTAL;
NEOADJUVANT THERAPY;
NEOPLASM INVASIVENESS;
PRACTICE GUIDELINES AS TOPIC;
RECEPTORS, ESTROGEN;
SENTINEL LYMPH NODE BIOPSY;
|
EID: 17144363073
PISSN: 15401405
EISSN: None
Source Type: None
DOI: None Document Type: Article |
Times cited : (8)
|
References (0)
|